This article was published twice in error during a change in production systems. The publisher apologizes to the authors and readers for the error. When citing this work, please refer to the original version.1
References
Counsell, J. R. et al. Lentiviral vectors can be used for full-length dystrophin gene therapy. Sci. Rep. 7, 79 (2017). 10.1038/s41598-017-00152-5.
Additional information
The online version of the original article can be found at 10.1038/srep44775
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Counsell, J., Asgarian, Z., Meng, J. et al. Erratum: Lentiviral vectors can be used for full-length dystrophin gene therapy. Sci Rep 7, 46880 (2017). https://doi.org/10.1038/srep46880
Published:
DOI: https://doi.org/10.1038/srep46880
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
